A04.7
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inpatients with underlying diseases causing in increased risk of C. difficile colonization/CDAD: a) malignant disease, b) s/p stem cell or solid organ transplantation, c) infiammatory bowel disease, d) hemodialysis, written informed consent
Exclusion criteria
Exclusion criteria: CDAD or suspected CDAD within 30 days prior to enrollment; diseases which prevent candidates to understand the nature and the consequences of the clinical trial; indications for protocol non-compliance
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients with CDAD, microbial pattern at baseline and at the final visit in colonized patients, microbial pattern at baseline and at the final visit in CDAD patients, disease course (severity, complications, recurrences) of CDAD, IgA and IgG repertoires in blood and intestinal mucosal samples | — |
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients with C. difficile colonization and -associated disease | — |
Countries
Germany
Contacts
MHH OE6810